64 related articles for article (PubMed ID: 6098806)
1. [Studies on the new anticancer preparation, 5-fluorouracil-polyglycolic acid-composite and its therapeutic evaluation].
Hirano M
Nihon Geka Gakkai Zasshi; 1984 Dec; 85(12):1508-17. PubMed ID: 6098806
[TBL] [Abstract][Full Text] [Related]
2. [Studies on the new long-acting anti-cancer preparation, 5-fluorouracil-polyglycolic acid composite].
Hirano M; Sakatoku M; Yamashita R; Iwa T
Gan To Kagaku Ryoho; 1984 Aug; 11(8):1569-72. PubMed ID: 6089666
[TBL] [Abstract][Full Text] [Related]
3. [A new anticancer preparation, 5-fluorouracil-poly-L-lactic acid microcapsule, and its therapeutic evaluation].
Sakatoku M; Hirano M; Yamashita R; Yamada T; Kawaura Y; Iwa T; Kitagawa S
Nihon Geka Gakkai Zasshi; 1986 Feb; 87(2):133-40. PubMed ID: 3713669
[TBL] [Abstract][Full Text] [Related]
4. [Experimental study of an anticancer drug delivery system using polylactic acid].
Yamashita R
Nihon Geka Gakkai Zasshi; 1987 Apr; 88(4):401-12. PubMed ID: 3587219
[TBL] [Abstract][Full Text] [Related]
5. Experimental studies and preliminary clinical trial of vinorelbine-loaded polymeric bioresorbable implants for the local treatment of solid tumors.
Fournier C; Hecquet B; Bouffard P; Vert M; Caty A; Vilain MO; Vanseymortier L; Merle S; Krikorian A; Lefebvre JL
Cancer Res; 1991 Oct; 51(19):5384-91. PubMed ID: 1913658
[TBL] [Abstract][Full Text] [Related]
6. Intraperitoneal 5-fluorouracil infusion for treatment of both peritoneal and liver micrometastases.
Archer S; Gray B
Surgery; 1990 Sep; 108(3):502-7. PubMed ID: 2396194
[TBL] [Abstract][Full Text] [Related]
7. [In-vivo 19F-MRS study of 5-fluorouracil (5-FU) metabolism on tumors].
Harada M; Nishitani H; Shirahama T; Koga K; Miura I
Gan To Kagaku Ryoho; 1991 Jan; 18(1):75-80. PubMed ID: 1899014
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of brain tumors with anticancer pellet--experimental and clinical study (author's transl)].
Oda Y; Uchida Y; Murata T; Mori K; Tokuriki Y; Handa H; Kobayashi A; Hashi K; Kieler J
No Shinkei Geka; 1982 Apr; 10(4):375-81. PubMed ID: 7099376
[TBL] [Abstract][Full Text] [Related]
9. 5-Fluorouracil plus leucovorin as adjuvant treatment of an experimental liver tumor in rats.
Carlsson G; Gustavsson BG; Spears CP; Hafström LO
Anticancer Res; 1990; 10(3):813-6. PubMed ID: 2369095
[TBL] [Abstract][Full Text] [Related]
10. Biochemical modulation of intraperitoneal fluorouracil by allopurinol-the effect on an experimental adenocarcinoma in the liver.
Lindnér P; Carlsson G; Gustavsson B; Holmberg SB; Naredi P; Peterson A; Hafström L
Anticancer Res; 1994; 14(3A):847-52. PubMed ID: 8074485
[TBL] [Abstract][Full Text] [Related]
11. Human soluble tumor-associated antigens promote the suppression of rat mammary tumors by 5-fluorouracil and stimulate the functional activity of immune organs: Experimental and morphological studies.
Kossoy G; Ben-Hur H; Avinoach I; Alhayany A; Shneider DF; Zusman I
Int J Mol Med; 2003 Nov; 12(5):797-801. PubMed ID: 14533012
[TBL] [Abstract][Full Text] [Related]
12. Synergistic inhibition of hepatocellular carcinoma growth and hepatocarcinogenesis by combination of 5-fluorouracil and angiotensin-converting enzyme inhibitor via anti-angiogenic activities.
Yanase K; Yoshiji H; Ikenaka Y; Noguchi R; Kitade M; Kaji K; Yoshii J; Namisaki T; Yamazaki M; Asada K; Tsujimoto T; Akahane T; Uemura M; Fukui H
Oncol Rep; 2007 Feb; 17(2):441-6. PubMed ID: 17203185
[TBL] [Abstract][Full Text] [Related]
13. Fluoropyrimidine chemotherapy in a rat model: comparison of fluorouracil metabolite profiles determined by high-field 19F-NMR spectroscopy of tissues ex vivo with therapy response and toxicity for locoregional vs systemic infusion protocols.
Lutz NW; Naser-Hijazi B; Koroma S; Berger MR; Hull WE
NMR Biomed; 2004 May; 17(3):101-31. PubMed ID: 15137037
[TBL] [Abstract][Full Text] [Related]
14. Subconjunctival sustained release 5-fluorouracil for glaucoma filtration surgery.
Cui LJ; Sun NX; Li XH; Huang J; Yang JG
Acta Pharmacol Sin; 2008 Sep; 29(9):1021-8. PubMed ID: 18718170
[TBL] [Abstract][Full Text] [Related]
15. [The mechanism of potentiation of the antitumor effect of 5-fluorouracil by methionine-free intravenous amino acid solution (AO-90) in rats].
Hibino Y; Kawarabayashi Y; Kohri H; Ueda N; Tsukagoshi S
Gan To Kagaku Ryoho; 1994 Sep; 21(12):2021-8. PubMed ID: 8085853
[TBL] [Abstract][Full Text] [Related]
16. Effects of local microwave hyperthermia and 5-fluorouracil in treatment of experimental liver cancer.
Hugander A; Bolmsjö M; Hafström L; Gustavsson B
Anticancer Res; 1985; 5(3):281-5. PubMed ID: 4015042
[TBL] [Abstract][Full Text] [Related]
17. Biodegradable three-dimension micro-device delivering 5-fluorouracil in tumor bearing mice.
Ren X; Zheng N; Gao Y; Chen T; Lu W
Drug Deliv; 2012 Jan; 19(1):36-44. PubMed ID: 22211757
[TBL] [Abstract][Full Text] [Related]
18. [Experimental studies on the optimal therapeutic mode of intra-arterial infusion of 5-fluorouracil. (2) Concentrations within the tumors and normal tissues and therapeutic and adverse effects of 5-fluorouracil delivered by various routes].
Ota J
Gan To Kagaku Ryoho; 1983 Nov; 10(11):2362-9. PubMed ID: 6639098
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcomes of needle revision of trabeculectomy blebs with mitomycin C and 5-fluorouracil: a comparative safety and efficacy report.
Anand N; Khan A
J Glaucoma; 2009 Sep; 18(7):513-20. PubMed ID: 19223788
[TBL] [Abstract][Full Text] [Related]
20. [Metabolic characteristics and antitumor activity of BOF-A2, a new 5-fluorouracil derivative].
Shirasaka T; Fukushima M; Shimamoto Y; Kimura Y; Ohshimo H; Imaoka T; Kimura A; Utsunomiya T; Fujii S
Gan To Kagaku Ryoho; 1990 May; 17(5):1051-8. PubMed ID: 2334171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
